ADMA Biologics Inc (ADMA) financial statements (2020 and earlier)

Company profile

Business Address C/O ADMA BIOLOGICS, INC.
RAMSEY, NJ 07446
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments27234315172229
Cash and cash equivalents27234310101726
Short-term investments   5653
Restricted cash and investments  2    
Receivables314110 
Inventory, net of allowances, customer advances and progress billings5319135322
Inventory5319135322
Other undisclosed current assets3220000
Total current assets:86456322212431
Noncurrent Assets
Property, plant and equipment323030  31
Intangible assets, net (including goodwill)788   
Goodwill444    
Intangible assets, net (excluding goodwill)345    
Deposits noncurrent assets3210000
Restricted cash and investments 44    
Deferred costs     00
Other undisclosed noncurrent assets 11  (3)(1)
Total noncurrent assets:4144450000
Other undisclosed assets   2231
TOTAL ASSETS:1278910824242732
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14995444
Accounts payable9663223
Accrued liabilities4432221
Interest and dividends payable     0 
Deferred revenue0
Debt00 6000
Deferred revenue and credits0    
Other liabilities  0    
Other undisclosed current liabilities 0 0000
Total current liabilities:1410911444
Noncurrent Liabilities
Long-term debt and lease obligation6827251214155
Long-term debt, excluding current maturities6826251214155
Capital lease obligations0 0000
Liabilities, other than long-term debt1715174422
Deferred revenue and credits33322
Deferred revenue2
Due to related parties151515    
Other liabilities0002100
Derivative instruments and hedges, liabilities     0 
Other undisclosed noncurrent liabilities118150000
Total noncurrent liabilities:8759581719177
Total liabilities:101696828232110
Stockholders' equity
Stockholders' equity attributable to parent, including:262040(4)1622
Common stock0000000
Additional paid in capital291236191102887574
Accumulated deficit(265)(216)(151)(107)(87)(69)(53)
Other undisclosed stockholders' equity attributable to parent  0    
Total stockholders' equity:262040(4)1622
TOTAL LIABILITIES AND EQUITY:1278910824242732

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues29172311763
Revenue, net1611763
Other operating income  7    
Cost of revenue(40)(42)(3)(6)(4)(4)(2)
Cost of goods and services sold  (29)(6)(4)(4)(2)
Other undisclosed gross profit  (26)    
Gross profit:(10)(25)(6)4321
Operating expenses(71)(77)(62)(28)(23)(22)(18)
Other undisclosed operating income4042296442
Operating loss:(41)(60)(39)(17)(16)(16)(15)
Nonoperating expense(7)(5)(4)(2)(2)(1)(0)
Investment income, nonoperating12   0(0)0
Interest and debt expense(10)(6)(1)(2)(1)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(58)(71)(45)(22)(19)(19)(16)
Other undisclosed income from continuing operations before income taxes   2111
Loss from continuing operations before income taxes:(58)(71)(45)(20)(18)(17)(16)
Income tax benefit     1 
Net loss:(58)(71)(45)(20)(18)(17)(16)
Other undisclosed net income attributable to parent1061    
Net loss available to common stockholders, diluted:(48)(66)(44)(20)(18)(17)(16)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(58)(71)(45)(20)(18)(17)(16)
Comprehensive loss, net of tax, attributable to parent:(58)(71)(45)(20)(18)(17)(16)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: